Terminologies

Evidence of health treatments efficacy

Evidence of Health Treatment Efficacy Implementation Guide published by Linca Telecomunicações Ltda. This guide is not an authorized publication; it is the continuous build for version 1.0.0. This version is based on the current content of <link> and changes regularly. See the Directory of published versions.

Terminologies

Page standards status: Informative

Terminologies

The Categorized Efficacy Outcomes is an externally maintained terminology, copyrighted by Linca Telecomunicações, and published openly by Linca Telecomunicações.

The Evidence-Based Medicine on FHIR Implementation Guide Code System and the Evidence Report Section Code Value Set are currently defined within the EBMonFHIR IG.

We are also using the concepts below to determine the type of treatment related to the artifact.

ATC: International standard for organizing drugs based on their organ system of action, therapeutic purpose, and chemical characteristics. We use ATC to identify drug treatments through their codes in their essence, based on the active ingredient and excluding the brand.
ICHI: System for standardized reporting and analysis of health interventions across clinical, primary care, and public health settings. We use ICHI to identify non-drug treatments through their codes.
GTIN: It is a globally unique identifier for products, such as pharmaceuticals and medical devices, used in supply chains to ensure accurate data capture and improve patient safety. We use it to identify the active ingredient of a drug treatment, representing its brand.
CID-11: The most recent edition of the International Classification of Diseases and Related Health Problems. We use ICD-11 to identify the disease through the code that represents it.

Code Systems

The Categorized Efficacy Outcomes is copyrighted by Linca Telecomunicações and published openly by Linca Telecomunicações.

The Evidence-Based Medicine on FHIR Implementation Guide Code System and the Evidence Report Section Code Value are currently defined within the EBMonFHIR IG.

See more information about the concept for the disease below:
Disease presented in the article: https://icd.who.int/dev11/l-ichi/en

See more information about the concepts for the type of treatment below:

Drug treatments that specify the brand name of the medication: https://icd.who.int/dev11/l-ichi/en
Drug treatments that specify the active ingredient and dosage of the medication: http://www.whocc.no/atc
Non-drug treatments: https://www.gs1.org/industries/healthcare

Category of evidence resources specifying health treatments efficacy in the Telix Implementation Guide:
https://treatments.telix.health/codesystem/categorized-efficacy-outcomes

SEVCO is a standardized terminology used to describe the design of a study in a computable way:
https://treatments.telix.health/codesystem/study-design-codeable-concept

Value Sets

Defines the clinical context types used to describe evidence in Telix, including the studied population, the evaluated intervention, and the measured clinical outcome.
https://treatments.telix.health/ValueSet/use-context-type

Defines the measured variable role used in Telix Evidence resources to identify the clinical outcome or characteristic being measured in a scientific study.
https://treatments.telix.health/ValueSet/variable-role

Telix Implementation Guide - 2026 - Linca Telecomunicações

Evidence of health treatments efficacy

Terminologies

Terminologies

Terminologies

Code Systems

Value Sets

Treatments Page

Scientific Articles Page

Create a FHIR resource

Documents

E-mail

Select the disease

Questions and answers